PSUSA/00001021/202411
PSUSA/00001021/202411
PSUSA/00001021/202411
IRIS guide for applicants - How to create, submit and manage IRIS applications, for industry and individual applicants
PSUSA/00009326/202411
PSUSA/00002047/202412
PSUSA/00001013/202411
PSUSA/00002257/202412
Human medicines European public assessment report (EPAR): Sugammadex Fresenius Kabi, sugammadex, Date of authorisation: 15/07/2022, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Epoetin Alfa Hexal, epoetin alfa, Date of authorisation: 27/08/2007, Revision: 27, Status: Authorised
Human medicines European public assessment report (EPAR): Binocrit, epoetin alfa, Date of authorisation: 28/08/2007, Revision: 25, Status: Authorised
Antimicrobial Sales and Use (ASU) Platform: Release notes